# Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis

> **NCT07154381** · — · RECRUITING · sponsor: **University Hospital, Essen** · enrollment: 25 (estimated)

## Conditions studied

- Cardiac Amyloidosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07154381
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-09
- **Primary completion:** 2025-10
- **Final completion:** 2025-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154381, "Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07154381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*